Yue Zhang

Yue Zhang is a seasoned professional in clinical research and development, currently serving as the Director, Clinical Research Scientist at Cullinan Oncology since February 2023. Prior experience includes directing clinical development at Repertoire Immune Medicines, leading solid tumor strategy at Karyopharm Therapeutics, and serving as a Solid Tumor MSL at AbbVie, where expertise contributed to the formulation of clinical and commercial strategies for oncology assets. Zhang's background also includes significant roles at EMD Serono as a Principal Scientist focusing on clinical biomarkers, and at AstraZeneca as a Senior Scientist managing drug discovery activities and patient stratification strategies. Early career experience includes a postdoctoral fellowship at Novartis, where novel regulatory mechanisms related to Wnt signaling were explored, resulting in publications in prominent scientific journals. Academic credentials include a Ph.D. in Cellular and Molecular Biology from the University of Wisconsin-Madison and a B.S. in Biological Science from Peking University.